Executive Vice President and General Counsel · HEALTHEQUITY, INC. (HQY)

Delano Ladd

A named executive officer of HEALTHEQUITY in every fiscal year CompBrief holds from FY2024 to FY2026. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2026

$3,634,598

FY2024: $2,636,149

Compensation figures as of the proxy filed May 13, 2026 (DEF 14A). Insider transactions since that proxy, current to 2026-09-24.

Delano Ladd compensation by year

HEALTHEQUITY Summary Compensation Table · all 2 fiscal years held
In US dollars, as HEALTHEQUITY reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2024FY2026
Salary$395,959$400,000
Bonus$0$0
Stock awards$1,882,225$2,924,656
Option awards$0$0
Non-equity incentive$341,515$297,000
Pension and deferred compensation$0$0
All other$16,450$12,942
Total$2,636,149$3,634,598

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: HEALTHEQUITY, INC. DEF 14A filed May 13, 2026, accession 0001428336-26-000022, and prior-year filings. Open the filing on EDGAR.

$2.6M
$3.6M
FY24
FY26
SalaryNon-equity incentiveStock awardsAll other

Equity holdings

unvested awards at FY2026 year-end
TypeUnvested unitsValue at year-endExercise price
PSU20,451$1,751,952—
PSU21,952$1,343,306—
PSU14,086$1,206,748—
RSU14,086$1,206,748—
RSU7,056$604,488—
RSU4,018$344,222—
RSU557$47,718—

Per the Outstanding Equity Awards at Fiscal Year-End table in HEALTHEQUITY, INC.'s FY2026 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

2 Form 4 lines since the FY2026 proxy (filed May 13, 2026)
current to 2026-09-24 · updated nightly
DateTransactionPlanSharesPriceHeld after
2026-07-08Tax withholding—1,087$95.0890,054
2026-05-28Sale10b5-17,500$90.0091,141

The 2 most recent of 2 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

Change-in-control & termination

estimated payments HEALTHEQUITY discloses, by trigger · FY2026
TriggerCash severanceAccelerated equityBenefits continuationTotal as disclosed
Change in control and resignation for good reason$400,000$6,224,354$31,204—
Involuntary termination without cause$400,000$0$31,204—
Resignation for good reason, no change in control$400,000$0$31,204—
Death$0$0$0—
Disability$0$0$0—
Change in control and involuntary termination$400,000$6,224,354$31,204—

Per the Potential Payments Upon Termination or Change in Control table in HEALTHEQUITY, INC.'s FY2026 proxy. Estimates as the company printed them; a dash means it printed no figure.

HEALTHEQUITY’s named executive officers, FY2026

as the company reported each
Named executive officerRoleFY2026 total
Scott CutlerPresident and Chief Executive Officer$13,582,105
James LucaniaExecutive Vice President and Chief Financial Officer$5,156,388
Elimelech RosnerFormer Executive Vice President and Chief Technology Officer$4,521,528
Michael FioreExecutive Vice President and Chief Commercial Officer$4,180,404
Delano Ladd · this pageExecutive Vice President and General Counsel$3,634,598
Stephen NeelemanFounder and Vice Chairman$3,499,924

The full HEALTHEQUITY compensation record

free company brief

This page is one person within HEALTHEQUITY's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order HEALTHEQUITY's full Executive Compensation Report with peer benchmarking.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are HEALTHEQUITY's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Velarion Pro: every company page, peer tools and exports, one seat

One email to you when Pro opens, and nothing else. Privacy